News
ALL: What Prompts A Post-Childhood ‘Survival Cliff’?
Despite changes in regimen, hematologists are haunted by the mystery of poor ALL outcomes as patients grow up.
News
ALL: ASH Draws Up Tx Guidelines For Patients 15-39
Unique factors of ALL pose challenges as ASH develops recommendations for treating teenagers and young adults.
News
Evidence Grows for SGLT2 Inhibitors in Rheumatology
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs...
News
ALL mortality gains bypass older adults
Despite more than 20 years of major advances in treating this leukemia, nationwide death rates among patients aged 55+ did not budge.
News
How scientists are uncovering the mysteries of ARDS
Under the microscope due to COVID-19, age-old lung disorder is giving up secrets.
Opinion
JAMA Internal Medicine Editor Recaps 2023’s High-Impact Research
Harvard geriatrician Dr. Sharon K. Inouye highlights research into long COVID, thyroid levels, silicosis, and more.
Opinion
New Insights, New Standards: How 2023 Changed Care for Internists
Dr. Sarah Candler explores the year’s big developments in HIV, RSV, anxiety, and atrial fibrillation.
News
Doctors Win $7 Million Settlement in EEOC Forced Retirement Case
“This policy was put in place to enhance patient safety,” Scripps said.
News
SCD mortality rates improved for Black patients in 2010s
The average age at death rose 4 years during that decade, but the transition from pediatric to adult care remains a major danger zone.
News
Sickle Cell: Good Outcomes for Haploidentical Transplants
Overall 2-year survival was 95% in a small, “robust” phase-2 trial of children and adults with sickle cell disease.
News
Mantle Cell Lymphoma: Drug Combo Improves PFS
Interim analysis of the new study, however, finds no statistically significant boost in overall survival.
News
In real world, patients with myeloma have worse outcomes
Canadian study indicates that real-world outcomes for patients treated for myeloma fall far short of those in clinical trials.
News
This test may guide AML therapy for Black pediatric patients
New research suggests that a polygenic score can presage how well Black pediatric patients with AML will respond to treatment.
News
Hematology is in the Brodsky family’s blood
Three generations of Brodsky men have forged careers in the same medical field.
News
ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes
Leaders of the American Society of Hematology preview hot topics and presentations on tap at their 2023 annual meeting.